Concepedia

John Conlon

JC

4

Publications

216

Citations

4

H-Index

1983

Active since

Affiliations

Frederick National Laboratory for Cancer Research(Current)

John Conlon is an author at Frederick National Laboratory for Cancer Research specializing in medicine, pharmacotherapy, and radiation oncology.

Top concepts

Publications per year

1983–1996

4

Publications

4

Depression of natural killer cytotoxicity after in vivo administration of recombinant leukocyte interferon.

A E Maluish, John R. Ortaldo, John Conlon et al. · The Journal of Immunology · 1983 · 102 citations · Full text

Amifostine improves the antileukemic therapeutic index of mafosfamide: implications for bone marrow purging

Luc Douay, Chen Hu, MC Giarratana et al. · Blood · 1995 · 62 citations · Full text

Characterization of biological response modifier release by human monocytes cultured in suspension in serum-free medium

Henry C. Stevenson, Eric Schlick, Richard Griffith et al. · Journal of Immunological Methods · 1984 · 26 citations

, , +5

WR-1065, the active metabolite of amifostine (ethyol®), does not inhibit the cytotoxic effects of a broad range of standard anticancer drugs against human ovarian and breast cancer cells

David S. Alberts, L A Speicher, Mary F. Krutzsch et al. · European Journal of Cancer · 1996 · 26 citations

, , +9

Rows per page

1–4 of 4